about
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its pro...
Read More
1.15
0.09
(8.49%)
531.6K
XNAS Volume
XNAS 16 Jan, 2026 4:30 PM (EST)
Not Eligible
Expensive Valuation
Technically Neutral
Equillium Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..